Journal
PROCESSES
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/pr11030735
Keywords
Pachyrhizus erosus; obesity; leptin-PPAR gamma-FAS; adipogenesis
Categories
Ask authors/readers for more resources
In 2016, 13% of the global adult population was obese. By 2030, this number is projected to reach 34%. Obesity is a non-communicable disease that can lead to various health problems. Study results showed that P. erosus effectively controls obesity by regulating leptin-C/EBPa-PPARgamma and FAS levels, and preventing lipid droplet accumulation.
In 2016, obese patients represented 13% of the worldwide adult population, and by 2030, they are projected to make up 34%. Obesity is an incommunicable disease, but it can induce many health problems. The groups consisted of a control, a 65% high-fat group, and a 250 mg/kg P. erosus group. Several biomarkers, such as body weight gain, the presence of TC/LDL/HDL in the serum, the weight of fat tissue, and liver weight/morphology, were investigated to define the anti-obesity mechanisms of P. erosus, and the adipogenesis pathway was studied. P. erosus suppressed body weight gain, decreased TC and LDL, prevented fat tissue weight gain, and prevented liver weight gain by blocking lipid droplet accumulation. P. erosus effectively decreased the up-regulated levels of leptin, significantly controlled both C/EBPa and PPAR gamma levels, and prevented increased FAS expression levels. We concluded that P. erosus effectively controlled obesity by regulating leptin-C/EBPa-PPAR gamma and FAS and might be a promising AOM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available